Literature DB >> 2404688

Structure and biosynthesis of the capsular antigens of Escherichia coli.

B Jann1, K Jann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2404688     DOI： 10.1007/978-3-642-74694-9_2

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  68 in total

1.  Genetic organization of the Escherichia coli K10 capsule gene cluster: identification and characterization of two conserved regions in group III capsule gene clusters encoding polysaccharide transport functions.

Authors:  B R Clarke; R Pearce; I S Roberts
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

2.  Escherichia coli K5 heparosan fermentation and improvement by genetic engineering.

Authors:  Zhenyu Wang; Jonathan S Dordick; Robert J Linhardt
Journal:  Bioeng Bugs       Date:  2011 Jan-Feb

3.  Transcriptional organization and regulation of expression of region 1 of the Escherichia coli K5 capsule gene cluster.

Authors:  D A Simpson; T C Hammarton; I S Roberts
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

4.  Biosynthesis of Klebsiella K2 capsular polysaccharide in Escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid (O1:K2).

Authors:  Y Arakawa; M Ohta; R Wacharotayankun; M Mori; N Kido; H Ito; T Komatsu; T Sugiyama; N Kato
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

5.  Characterization of Escherichia coli D-arabinose 5-phosphate isomerase encoded by kpsF: implications for group 2 capsule biosynthesis.

Authors:  Timothy C Meredith; Ronald W Woodard
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

6.  A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Stacy A Genagon; Ulrike MacDonald; John J Cope; Bruce A Davidson; Brian Johnston; James R Johnson
Journal:  Vaccine       Date:  2007-02-05       Impact factor: 3.641

7.  Structural determination of a 5-O-methyl-deaminated neuraminic acid (Kdn)-containing polysaccharide isolated from Sinorhizobium fredii.

Authors:  A M Gil-Serrano; M A Rodríguez-Carvajal; P Tejero-Mateo; J L Espartero; J Thomas-Oates; J E Ruiz-Sainz; A M Buendía-Clavería
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

8.  RmpA2, an activator of capsule biosynthesis in Klebsiella pneumoniae CG43, regulates K2 cps gene expression at the transcriptional level.

Authors:  Yi-Chyi Lai; Hwei-Ling Peng; Hwan-You Chang
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

9.  Involvement of phospholipid end groups of group C Neisseria meningitidis and Haemophilus influenzae type b polysaccharides in association with isolated outer membranes and in immunoassays.

Authors:  G Arakere; A L Lee; C E Frasch
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

10.  Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; M Poppelier; K Kraaijeveld; J Verhoef
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.